Medtronic Bolsters Neurovascular Portfolio With $550M Scientia Buy

 
• By Shubham Singh
  
The acquisition of Scientia is expected to strengthen Medtronic's technological capabilities in the neurovascular field and may better position the company to respond to future innovations. Picture Courtesy: Shutterstock

More from Deals

More from Business